Wednesday, February 1, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosurveillance

Study Shows Potential for Wastewater-Based Epidemiology to Monitor Monkeypox

by Global Biodefense Staff
September 9, 2022
3 large open flasks atop a drip arrangement of filters in a laboratory

This photograph was captured during one of the steps in an environmental surveillance technique, using a filtration-based method. The benefits include not having to be incubated overnight in the cold, and that it uses three filters at one time, proving to be faster, and cheaper. Credit: CDC / Holly Patrick, MS, MPH

Gaps in current clinical testing availability for monkeypox and the lag from infection to symptoms suggest the potential utility of wastewater-based epidemiology to monitor community level spread and prevalence.

In a new study, researchers demonstrate how wastewater epidemiology — widely applied to monitor SARS-CoV-2 transmission — could be optimized for monkeypox, potentially detecting as few as seven infections per 100,000 people.

Like SARS-CoV-2, the monkeypox virus can shed from infected people through their feces, urine and saliva. Recently, researchers have detected its DNA in wastewater using polymerase chain reaction (PCR) assays. However, monitoring current monkeypox outbreaks in the U.S. with wastewater-based epidemiology has been limited, despite its success in tracking community-level SARS-CoV-2 prevalence. So, Kyle Bibby and William Chen wanted to evaluate the feasibility of this technique for detecting monkeypox viral DNA in different wastewater scenarios.

The researchers collected information from previous scientific studies about the shedding of monkeypox viral DNA from saliva, stool and urine into wastewater streams. They analyzed that data in combination with people’s daily water usage, concluding that infected people can shed from 13,000 to 208 billion genome copies daily into sewers, with most of that amount coming from stool. These results indicated that a single PCR assay conducted at the lowest level of sensitivity, or 10 genome copies per liter of wastewater, could theoretically detect seven cases out of 100,000 people at the average U.S. wastewater treatment plant. In addition, replicate assays could likely identify even lower infection rates.

Next, the team developed a computer-based strategy to determine the number of PCR assays that would need to be run for wastewater samples collected in the U.S. and other countries, depending on the expected case rates of monkeypox and the desired level of sensitivity. For the U.S., at the average case rate as of July 15, 2022, each sample would need eight replicate assays using a moderately high level of sensitivity to correctly detect monkeypox in the sewage, whereas at a suspected maximum case rate (0.0012%) only four replicates at a lower level of sensitivity would be needed. Since mid-July, case rates have likely increased, so the researchers predict that a lower number of replicates could be implemented now in the U.S.

There is still a lack of information about monkeypox DNA shedding from humans and its persistence in wastewater, which merits further study. This computer model can nonetheless be a useful framework for developing robust community monitoring programs.

Model-Based Theoretical Evaluation of the Feasibility of Using Wastewater-Based Epidemiology to Monitor Monkeypox. Environmental Science & Technology Letters, 1 September 2022.

Tags: Editor PickEmerging ThreatsEpidemiologyMonkeypoxPublic Health EmergencyWastewater Surveillance

Related Posts

New Virus Discovered in Swiss Ticks
Biosurveillance

New Virus Discovered in Swiss Ticks

December 7, 2022
Why Do Some of the Outbreak Genomes Have More Mutations Than Others?
Biosurveillance

Virginia Institutes Partner to Join National Pathogen Genomics Centers of Excellence Network

October 25, 2022
Researcher holds a pipette
Biodetection

These Nanotech Bubbles Burst When They Detect Viruses in the Air

October 25, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies
Biosurveillance

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC